Related Experiment Video
Updated: Jun 5, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Twenty-five novel mutations including duplications in the ATP7A gene
M-P Moizard1, N Ronce, S Blesson
1CHRU de Tours, Service de Génétique, Tours, F-37044, France INSERM U930, Tours, F-37044, France CHU Hôpital Purpan, Service de Génétique médicale, Toulouse, F-31059, France CHU Hôpital d'Enfants Armand-Trousseau, AP-HP, Service de Génétique et Embryologie médicales, Paris, F-75571, France CHU Hôpital d'Enfants Armand-Trousseau, AP-HP, Service de Neuropédiatrie, Paris, F-75012, France Genetica Medica, Università di Pavia, Fondazione IRCCS S. Matteo, Pavia, I-27100, Italie Centre de Référence des Maladies Héréditaires du Métabolisme, INSERM U954. Hôpital d'Enfants, Vandoeuvre les Nancy, F-54511, France CHRU de Tours, Service de Neuropédiatrie, Tours, F-37044 France; Université François Rabelais Tours, F-37044, France.
This study identified 25 new mutations, including duplications, in the ATP7A gene linked to Menkes disease and occipital horn syndrome. These findings expand the known spectrum of ATP7A alterations causing copper deficiency disorders.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Menkes disease (MD) and occipital horn syndrome (OHS) are X-linked disorders caused by ATP7A gene mutations, leading to copper deficiency.
- MD presents severe neurological issues, while OHS involves connective tissue abnormalities.
- Previous studies identified deletions and point mutations in ATP7A.
Purpose of the Study:
- To identify novel mutations in the ATP7A gene in patients with MD or OHS.
- To expand the understanding of the mutation spectrum associated with these allelic disorders.
- To investigate the frequency and types of ATP7A alterations in a cohort of patients.
Main Methods:
- Molecular analysis of the ATP7A gene in 40 patients with suspected MD or OHS.
- Identification and characterization of point mutations (missense, splice site, nonsense, insertions/deletions) and large rearrangements (deletions, duplications).
Main Results:
- Identified 25 novel mutations in the ATP7A gene, including 23 point mutations and 7 intragenic deletions.
- Discovered four whole exon duplications, broadening the known mutation types.
- ATP7A alterations were detected in 85% of patients, with two-thirds being point mutations and one-third large rearrangements.
- 66.6% of point mutations impaired ATP7A transcript splicing, a higher frequency than anticipated.
Conclusions:
- The study expands the spectrum of ATP7A mutations associated with MD and OHS, including novel point mutations and duplications.
- Impaired ATP7A transcript splicing is a frequent consequence of point mutations in these disorders.
- The findings confirm the pathogenic role of ATP7A mutations, especially missense and splice site variants, in copper deficiency disorders.
Related Concept Videos
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Mutations
Cancers Originate from Somatic Mutations in a Single Cell
Gene Duplication and Divergence
The duplicated copies of the gene are called Paralogs. Paralogs with similar sequences and functions form a gene family. Across several species, a large number of gene families are characterized.
Genome Copying Errors

